New regulatory CD19+CD25+ B-cell subset in clinically isolated syndrome and multiple sclerosis relapse. Changes after glucocorticoids

Journal of Neuroimmunology

Volumn 270, Issue 1-2, 2014, Pages 37-44

  De Andrés, Clara ^a   Tejera Alhambra, Marta ^a   Alonso, Bárbara ^a   Valor, Lara ^a   Teijeiro, Roseta ^a   Ramos Medina, Rocío ^a   Mateos, Dolores ^a   Faure, Florence ^b   Sánchez Ramón, Silvia ^a,c  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b PSL RESEARCH UNIVERSITY   (France)

^c HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Multiple sclerosis, cerebrospinal fluid; Perforin expression, methylprednisolone; Regulatory B lymphocytes

Indexed keywords

MULTIPLE SCLEROSIS, CEREBROSPINAL FLUID; PERFORIN EXPRESSION, METHYLPREDNISOLONE; REGULATORY B-LYMPHOCYTES;

ADULT; ANTIGENS, CD19; B-LYMPHOCYTES, REGULATORY; CROSS-SECTIONAL STUDIES; DEMYELINATING DISEASES; FEMALE; GLUCOCORTICOIDS; GRANZYMES; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PERFORIN; RECURRENCE; T-LYMPHOCYTES, REGULATORY; YOUNG ADULT;

EID: 84898799783     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.02.003     Document Type: Article

References (46)

1. Agematsu K., Hokibara S., Nagumo H., Komiyama A. CD27: a memory B-cell marker. Immunol. Today 2000, 21:204-206.
2. Amu S., Tarkowski A., Dorner T., Bokarewa M., Brisslert M. The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool. Scand. J. Immunol. 2007, 66:77-86.
3. Anderton S.M., Fillatreau S. Activated B cells in autoimmune diseases: the case for a regulatory role. Nat. Clin. Pract. Rheumatol. 2008, 4:657-666.
4. Aristimuño C., Navarro J., de Andres C., Martinez-Gines L., Gimenez-Roldan S., Fernandez-Cruz E., Sanchez-Ramon S. Expansion of regulatory CD8+ T-lymphocytes and fall of activated CD8+ T-lymphocytes after i.v. methyl-prednisolone for multiple sclerosis relapse. J. Neuroimmunol. 2008, 204:131-135.
5. Beltran E., Hernandez A., Lafuente E.M., Coret F., Simo-Castello M., Bosca I., Perez-Miralles F.C., Burgal M., Casanova B. Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis. J. Neuroimmunol. 2012, 247:63-69.
6. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., Koup R.A. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J. Immunol. Methods 2003, 281(1-2):65-78. (Oct 1).
7. Brisslert M., Bokarewa M., Larsson P., Wing K., Collins L.V., Tarkowski A. Phenotypic and functional characterization of human CD25+ B cells. Immunology 2006, 117:548-557.
8. Cepok S., Rosche B., Grummel V., Vogel F., Zhou D., Sayn J., Sommer N., Hartung H.P., Hemmer B. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain 2005, 128:1667-1676.
9. Corcione A., Casazza S., Ferretti E., Giunti D., Zappia E., Pistorio A., Gambini C., Mancardi G.L., Uccelli A., Pistoia V. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:11064-11069.
10. Chavez-Galan L., Arenas-Del Angel M.C., Zenteno E., Chavez R., Lascurain R. Cell death mechanisms induced by cytotoxic lymphocytes. Cell. Mol. Immunol. 2009, 6:15-25.
11. De Andrés C., Vicente A., Sánchez-Ramón S., Sacedón R., Gutierrez C., Zapata A. High numbers of activated dendritic cells in blood and cerebrospinal fluid of multiple sclerosis patients. Rev. Neurol. 2000, (Paris) 156, S154.
12. Elovaara I., Ukkonen M., Leppakynnas M., Lehtimaki T., Luomala M., Peltola J., Dastidar P. Adhesion molecules in multiple sclerosis: relation to subtypes of disease and methylprednisolone therapy. Arch. Neurol. 2000, 57:546-551.
13. Eriksson P., Sandell C., Backteman K., Ernerudh J. B cell abnormalities in Wegener's granulomatosis and microscopic polyangiitis: role of CD25+-expressing B cells. J. Rheumatol. 2010, 37:2086-2095.
14. Feger U., Luther C., Poeschel S., Melms A., Tolosa E., Wiendl H. Increased frequency of CD4+ CD25+ regulatory T cells in the cerebrospinal fluid but not in the blood of multiple sclerosis patients. Clin. Exp. Immunol. 2007, 147:412-418.
15. Fritzsching B., Haas J., Konig F., Kunz P., Fritzsching E., Poschl J., Krammer P.H., Bruck W., Suri-Payer E., Wildemann B. Intracerebral human regulatory T cells: analysis of CD4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients. PLoS One 2011, 6:e17988.
16. Hu W., Lucchinetti C.F. The pathological spectrum of CNS inflammatory demyelinating diseases. Semin. Immunopathol. 2009, 31:439-453.
17. Kessel A., Haj T., Peri R., Snir A., Melamed D., Sabo E., Toubi E. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun. Rev. 2012, 11:670-677.
18. Knippenberg S., Peelen E., Smolders J., Thewissen M., Menheere P., Cohen Tervaert J.W., Hupperts R., Damoiseaux J. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive/memory Breg ratio during a relapse but not in remission. J. Neuroimmunol. 2011, 239:80-86.
19. Krystyna M.S., Jacek T., Sebastian R., Ewa B., Halina B.P., Zbigniew S., Jacek R. Changes in circulating dendritic cells and B-cells in patients with multiple sclerosis relapse during corticosteroid therapy. J. Neuroimmunol. 2009, 207:107-110.
20. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452.
21. Lassmann H., Bruck W., Lucchinetti C.F. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 2007, 17:210-218.
22. Lee-Chang C., Zephir H., Top I., Dubucquoi S., Trauet J., Prin L., Vermersch P. B-cell subsets up-regulate alpha4 integrin and accumulate in the cerebrospinal fluid in clinically isolated syndrome suggestive of multiple sclerosis onset. Neurosci. Lett. 2011, 487:273-277.
23. Lichtenheld M.G., Olsen K.J., Lu P., Lowrey D.M., Hameed A., Hengartner H., Podack E.R. Structure and function of human perforin. Nature 1988, 335:448-451.
24. Lisak R.P., Benjamins J.A., Nedelkoska L., Barger J.L., Ragheb S., Fan B., Ouamara N., Johnson T.A., Rajasekharan S., Bar-Or A. Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro. J. Neuroimmunol. 2012, 246:85-95.
25. Lucchinetti C.F., Bruck W., Lassmann H. Evidence for pathogenic heterogeneity in multiple sclerosis. Ann. Neurol. 2004, 56:308.
26. Lund F.E., Randall T.D. Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nat. Rev. Immunol. 2010, 10:236-247.
27. Miller D.H., Chard D.T., Ciccarelli O. Clinically isolated syndromes. Lancet Neurol. 2012, 11:157-169.
28. Navarro J., Aristimuno C., Sanchez-Ramon S., Vigil D., Martinez-Gines M.L., Fernandez-Cruz E., de Andres C. Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: differential short-term changes on corticosteroids therapy. J. Neuroimmunol. 2006, 176:153-161.
29. Niino M., Bodner C., Simard M.L., Alatab S., Gano D., Kim H.J., Trigueiro M., Racicot D., Guerette C., Antel J.P., Fournier A., Grand'Maison F., Bar-Or A. Natalizumab effects on immune cell responses in multiple sclerosis. Ann. Neurol. 2006, 59:748-754.
30. Noh G., Lee J.H. Regulatory B cells and allergic diseases. Allergy Asthma Immunol. Res. 2011, 3:168-177.
31. Paul C., Bolton C. Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A. Int. J. Immunopharmacol. 1995, 17:497-503.
32. Polman C.H., Reingold S.C., Banwell B., Clanet M., Cohen J.A., Filippi M., Fujihara K., Havrdova E., Hutchinson M., Kappos L., Lublin F.D., Montalban X., O'Connor P., Sandberg-Wollheim M., Thompson A.J., Waubant E., Weinshenker B., Wolinsky J.S. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 2011, 69:292-302.
33. Porakishvili N., Mageed R., Jamin C., Pers J.O., Kulikova N., Renaudineau Y., Lydyard P.M., Youinou P. Recent progress in the understanding of B-cell functions in autoimmunity. Scand. J. Immunol. 2001, 54:30-38.
34. Qin Y., Duquette P., Zhang Y., Talbot P., Poole R., Antel J. Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. J. Clin. Invest. 1998, 102:1045-1050.
35. Sadaba M.C., Tzartos J., Paino C., Garcia-Villanueva M., Alvarez-Cermeno J.C., Villar L.M., Esiri M.M. Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions. J. Neuroimmunol. 2012, 247:86-94.
36. Sánchez-Ramón S., Navarro J., Jiménez B., Rodríguez-Mahou M., Rodríguez-Sáinz C., Giménez-Roldán S., Fernández-Cruz E., De Andrés C. Mature dendritic cells subsets are recruited in cerebrospinal fluid and may be locally priming T-cells and recruiting regulatory T-cells at first clinical relapse of multiple sclerosis. Mult. Scler. 2004, 7032(10):171. (S2S).
37. Sellebjerg F., Bornsen L., Khademi M., Krakauer M., Olsson T., Frederiksen J.L., Sorensen P.S. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology 2009, 73:2003-2010.
38. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 2004, 14:164-174.
39. Silverman G.J., Carson D.A. Roles of B cells in rheumatoid arthritis. Arthritis Res. Ther. 2003, 5(Suppl. 4):S1-S6.
40. Stahn C., Buttgereit F. Genomic and nongenomic effects of glucocorticoids. Nat. Clin. Pract. Rheumatol. 2008, 4:525-533.
41. Tejera-Alhambra M., Alonso B., Teijeiro R., Ramos-Medina R., Aristimuno C., Valor L., de Andres C., Sanchez-Ramon S. Perforin expression by CD4+ regulatory T cells increases at multiple sclerosis relapse: sex differences. Int. J. Mol. Sci. 2012, 13:6698-6710.
42. Tischner D., Reichardt H.M. Glucocorticoids in the control of neuroinflammation. Mol. Cell. Endocrinol. 2007, 275:62-70.
43. Trapani J.A., Smyth M.J. Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. 2002, 2:735-747.
44. Valor L., Teijeiro R., Aristimuno C., Faure F., Alonso B., de Andres C., Tejera M., Lopez-Lazareno N., Fernandez-Cruz E., Sanchez-Ramon S. Estradiol-dependent perforin expression by human regulatory T-cells. Eur. J. Clin. Invest. 2011, 41:357-364.
45. Villar L.M., Espino M., Cavanillas M.L., Roldan E., Urcelay E., de la Concha E.G., Sadaba M.C., Arroyo R., Gonzalez-Porque P., Alvarez-Cermeno J.C. Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis. Clin. Immunol. 2010, 137:51-59.
46. von Budingen H.C., Bar-Or A., Zamvil S.S. B cells in multiple sclerosis: connecting the dots. Curr. Opin. Immunol. 2011, 23:713-720.